[Blood platelet disorders. II. Acquired thrombocytopathies and action of drugs on platelet function].
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects*; D001791:Blood Platelet Disorders / Q000097:blood / Q000139:chemically induced*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D004176:Dipyridamole / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D011453:Prostaglandins / Q000096:biosynthesis; D011619:Psychotropic Drugs / Q000009:adverse effects; D014508:Urea / Q000378:metabolism; D014511:Uremia / Q000097:blood
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D011619:Psychotropic Drugs; D004176:Dipyridamole; D014508:Urea; D001241:Aspirin
Zaburzenia czynności płytek krwi. II. Nabyte trombocytopatie i wpłlyw leków na funkcje płytek.